L'Oréal S.A. (OR.PA)
| Previous Close | 367.70 |
| Open | 371.45 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 364.55 - 372.30 |
| 52 Week Range | 364.55 - 461.85 |
| Volume | |
| Avg. Volume | 327,194 |
| Market Cap | 195.366B |
| Beta (5Y Monthly) | 0.71 |
| PE Ratio (TTM) | 30.18 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 6.60 (1.79%) |
| Ex-Dividend Date | Apr 26, 2024 |
| 1y Target Est | N/A |
- Yahoo Finance UK
Five alternatives to Mag 7 stocks if you missed out on Nvidia
Can the Magnificent Seven retain its crown? Here are other stocks to look at.
- Investing.com
Jefferies raises L'Oréal to 'Hold' but remains cautious in the medium term
Investing.com - Jefferies International analysts upgraded their rating on CAC 40 member L'Oréal (EPA:OREP) to "Hold" from "Underperform" in a note released on Wednesday.
- Reuters
L'Oreal to buy 10% stake in Swiss skincare firm Galderma
ZURICH/PARIS (Reuters) -L'Oreal will acquire a 10% stake in Swiss skin care firm Galderma from a group of major shareholders, the two companies said on Monday, as the French firm seeks a cut of the profits from the booming injectable cosmetics market. Galderma, originally set up as a joint venture between Nestle and L'Oreal before the latter sold its 50% stake in 2014, listed an initial tranche of its stock in late March. L'Oreal is buying the stake at an undisclosed premium from Sunshine SwissCo AG - a consortium led by Swedish private equity firm EQT - Abu Dhabi Investment Authority and Auba Investment Pte. Ltd in a deal due to be completed in the coming days.
